カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界のシタラビン＆ダウノルビシン市場予測2023-2029：ダウノルビシン29mg/m2＆シタラビン65mg/m2、ダウノルビシン44mg/m2＆シタラビン100mg/m2

【英語タイトル】Cytarabine and Daunorubicin Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8445）・商品コード：MMG23LY8445
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：72
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のシタラビン＆ダウノルビシン市場規模と予測を収録しています。・世界のシタラビン＆ダウノルビシン市場：売上、2018年-2023年、2024年-2029年
・世界のシタラビン＆ダウノルビシン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のシタラビン＆ダウノルビシン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ダウノルビシン29mg/m2＆シタラビン65mg/m2」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

シタラビン＆ダウノルビシンのグローバル主要企業は、Celator Pharmaceuticals、 Jazz Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、シタラビン＆ダウノルビシンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のシタラビン＆ダウノルビシン市場：タイプ別、2018年-2023年、2024年-2029年
世界のシタラビン＆ダウノルビシン市場：タイプ別市場シェア、2022年
・ダウノルビシン29mg/m2＆シタラビン65mg/m2、ダウノルビシン44mg/m2＆シタラビン100mg/m2

世界のシタラビン＆ダウノルビシン市場：用途別、2018年-2023年、2024年-2029年
世界のシタラビン＆ダウノルビシン市場：用途別市場シェア、2022年
・病院、薬局

世界のシタラビン＆ダウノルビシン市場：地域・国別、2018年-2023年、2024年-2029年
世界のシタラビン＆ダウノルビシン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるシタラビン＆ダウノルビシンのグローバル売上、2018年-2023年
・主要企業におけるシタラビン＆ダウノルビシンのグローバル売上シェア、2022年
・主要企業におけるシタラビン＆ダウノルビシンのグローバル販売量、2018年-2023年
・主要企業におけるシタラビン＆ダウノルビシンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Celator Pharmaceuticals、 Jazz Pharma

*************************************************************

・調査・分析レポートの概要
シタラビン＆ダウノルビシン市場の定義
市場セグメント
世界のシタラビン＆ダウノルビシン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のシタラビン＆ダウノルビシン市場規模
世界のシタラビン＆ダウノルビシン市場規模：2022年 VS 2029年
世界のシタラビン＆ダウノルビシン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのシタラビン＆ダウノルビシンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のシタラビン＆ダウノルビシン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ダウノルビシン29mg/m2＆シタラビン65mg/m2、ダウノルビシン44mg/m2＆シタラビン100mg/m2
シタラビン＆ダウノルビシンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、薬局
シタラビン＆ダウノルビシンの用途別グローバル売上・予測

・地域別市場分析
地域別シタラビン＆ダウノルビシン市場規模 2022年と2029年
地域別シタラビン＆ダウノルビシン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Celator Pharmaceuticals、 Jazz Pharma
...

VYXEOS is a liposomal combination of daunorubicin, an anthracycline topoisomerase inhibitor, and cytarabine,
This report aims to provide a comprehensive presentation of the global market for Cytarabine and Daunorubicin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cytarabine and Daunorubicin. This report contains market size and forecasts of Cytarabine and Daunorubicin in global, including the following market information:
Global Cytarabine and Daunorubicin Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Cytarabine and Daunorubicin Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Cytarabine and Daunorubicin companies in 2022 (%)
The global Cytarabine and Daunorubicin market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Daunorubicin 29 mg/m2 and Cytarabine 65 mg/m2 Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Cytarabine and Daunorubicin include Celator Pharmaceuticals and Jazz Pharma etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cytarabine and Daunorubicin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cytarabine and Daunorubicin Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cytarabine and Daunorubicin Market Segment Percentages, by Type, 2022 (%)
Daunorubicin 29 mg/m2 and Cytarabine 65 mg/m2
Daunorubicin 44 mg/m2 and Cytarabine 100 mg/m2
Global Cytarabine and Daunorubicin Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cytarabine and Daunorubicin Market Segment Percentages, by Application, 2022 (%)
Hospital
Pharmacy
Global Cytarabine and Daunorubicin Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Cytarabine and Daunorubicin Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cytarabine and Daunorubicin revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Cytarabine and Daunorubicin revenues share in global market, 2022 (%)
Key companies Cytarabine and Daunorubicin sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Cytarabine and Daunorubicin sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Celator Pharmaceuticals
Jazz Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of Cytarabine and Daunorubicin, market overview.
Chapter 2: Global Cytarabine and Daunorubicin market size in revenue and volume.
Chapter 3: Detailed analysis of Cytarabine and Daunorubicin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Cytarabine and Daunorubicin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Cytarabine and Daunorubicin capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Cytarabine and Daunorubicin Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Cytarabine and Daunorubicin Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Cytarabine and Daunorubicin Overall Market Size
2.1 Global Cytarabine and Daunorubicin Market Size: 2022 VS 2029
2.2 Global Cytarabine and Daunorubicin Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Cytarabine and Daunorubicin Sales: 2018-2029
3 Company Landscape
3.1 Top Cytarabine and Daunorubicin Players in Global Market
3.2 Top Global Cytarabine and Daunorubicin Companies Ranked by Revenue
3.3 Global Cytarabine and Daunorubicin Revenue by Companies
3.4 Global Cytarabine and Daunorubicin Sales by Companies
3.5 Global Cytarabine and Daunorubicin Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Cytarabine and Daunorubicin Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Cytarabine and Daunorubicin Product Type
3.8 Tier 1, Tier 2 and Tier 3 Cytarabine and Daunorubicin Players in Global Market
3.8.1 List of Global Tier 1 Cytarabine and Daunorubicin Companies
3.8.2 List of Global Tier 2 and Tier 3 Cytarabine and Daunorubicin Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Cytarabine and Daunorubicin Market Size Markets, 2022 & 2029
4.1.2 Daunorubicin 29 mg/m2 and Cytarabine 65 mg/m2
4.1.3 Daunorubicin 44 mg/m2 and Cytarabine 100 mg/m2
4.2 By Type – Global Cytarabine and Daunorubicin Revenue & Forecasts
4.2.1 By Type – Global Cytarabine and Daunorubicin Revenue, 2018-2023
4.2.2 By Type – Global Cytarabine and Daunorubicin Revenue, 2024-2029
4.2.3 By Type – Global Cytarabine and Daunorubicin Revenue Market Share, 2018-2029
4.3 By Type – Global Cytarabine and Daunorubicin Sales & Forecasts
4.3.1 By Type – Global Cytarabine and Daunorubicin Sales, 2018-2023
4.3.2 By Type – Global Cytarabine and Daunorubicin Sales, 2024-2029
4.3.3 By Type – Global Cytarabine and Daunorubicin Sales Market Share, 2018-2029
4.4 By Type – Global Cytarabine and Daunorubicin Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Cytarabine and Daunorubicin Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Pharmacy
5.2 By Application – Global Cytarabine and Daunorubicin Revenue & Forecasts
5.2.1 By Application – Global Cytarabine and Daunorubicin Revenue, 2018-2023
5.2.2 By Application – Global Cytarabine and Daunorubicin Revenue, 2024-2029
5.2.3 By Application – Global Cytarabine and Daunorubicin Revenue Market Share, 2018-2029
5.3 By Application – Global Cytarabine and Daunorubicin Sales & Forecasts
5.3.1 By Application – Global Cytarabine and Daunorubicin Sales, 2018-2023
5.3.2 By Application – Global Cytarabine and Daunorubicin Sales, 2024-2029
5.3.3 By Application – Global Cytarabine and Daunorubicin Sales Market Share, 2018-2029
5.4 By Application – Global Cytarabine and Daunorubicin Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Cytarabine and Daunorubicin Market Size, 2022 & 2029
6.2 By Region – Global Cytarabine and Daunorubicin Revenue & Forecasts
6.2.1 By Region – Global Cytarabine and Daunorubicin Revenue, 2018-2023
6.2.2 By Region – Global Cytarabine and Daunorubicin Revenue, 2024-2029
6.2.3 By Region – Global Cytarabine and Daunorubicin Revenue Market Share, 2018-2029
6.3 By Region – Global Cytarabine and Daunorubicin Sales & Forecasts
6.3.1 By Region – Global Cytarabine and Daunorubicin Sales, 2018-2023
6.3.2 By Region – Global Cytarabine and Daunorubicin Sales, 2024-2029
6.3.3 By Region – Global Cytarabine and Daunorubicin Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Cytarabine and Daunorubicin Revenue, 2018-2029
6.4.2 By Country – North America Cytarabine and Daunorubicin Sales, 2018-2029
6.4.3 US Cytarabine and Daunorubicin Market Size, 2018-2029
6.4.4 Canada Cytarabine and Daunorubicin Market Size, 2018-2029
6.4.5 Mexico Cytarabine and Daunorubicin Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Cytarabine and Daunorubicin Revenue, 2018-2029
6.5.2 By Country – Europe Cytarabine and Daunorubicin Sales, 2018-2029
6.5.3 Germany Cytarabine and Daunorubicin Market Size, 2018-2029
6.5.4 France Cytarabine and Daunorubicin Market Size, 2018-2029
6.5.5 U.K. Cytarabine and Daunorubicin Market Size, 2018-2029
6.5.6 Italy Cytarabine and Daunorubicin Market Size, 2018-2029
6.5.7 Russia Cytarabine and Daunorubicin Market Size, 2018-2029
6.5.8 Nordic Countries Cytarabine and Daunorubicin Market Size, 2018-2029
6.5.9 Benelux Cytarabine and Daunorubicin Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Cytarabine and Daunorubicin Revenue, 2018-2029
6.6.2 By Region – Asia Cytarabine and Daunorubicin Sales, 2018-2029
6.6.3 China Cytarabine and Daunorubicin Market Size, 2018-2029
6.6.4 Japan Cytarabine and Daunorubicin Market Size, 2018-2029
6.6.5 South Korea Cytarabine and Daunorubicin Market Size, 2018-2029
6.6.6 Southeast Asia Cytarabine and Daunorubicin Market Size, 2018-2029
6.6.7 India Cytarabine and Daunorubicin Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Cytarabine and Daunorubicin Revenue, 2018-2029
6.7.2 By Country – South America Cytarabine and Daunorubicin Sales, 2018-2029
6.7.3 Brazil Cytarabine and Daunorubicin Market Size, 2018-2029
6.7.4 Argentina Cytarabine and Daunorubicin Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Cytarabine and Daunorubicin Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Cytarabine and Daunorubicin Sales, 2018-2029
6.8.3 Turkey Cytarabine and Daunorubicin Market Size, 2018-2029
6.8.4 Israel Cytarabine and Daunorubicin Market Size, 2018-2029
6.8.5 Saudi Arabia Cytarabine and Daunorubicin Market Size, 2018-2029
6.8.6 UAE Cytarabine and Daunorubicin Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Celator Pharmaceuticals
7.1.1 Celator Pharmaceuticals Company Summary
7.1.2 Celator Pharmaceuticals Business Overview
7.1.3 Celator Pharmaceuticals Cytarabine and Daunorubicin Major Product Offerings
7.1.4 Celator Pharmaceuticals Cytarabine and Daunorubicin Sales and Revenue in Global (2018-2023)
7.1.5 Celator Pharmaceuticals Key News & Latest Developments
7.2 Jazz Pharma
7.2.1 Jazz Pharma Company Summary
7.2.2 Jazz Pharma Business Overview
7.2.3 Jazz Pharma Cytarabine and Daunorubicin Major Product Offerings
7.2.4 Jazz Pharma Cytarabine and Daunorubicin Sales and Revenue in Global (2018-2023)
7.2.5 Jazz Pharma Key News & Latest Developments
8 Global Cytarabine and Daunorubicin Production Capacity, Analysis
8.1 Global Cytarabine and Daunorubicin Production Capacity, 2018-2029
8.2 Cytarabine and Daunorubicin Production Capacity of Key Manufacturers in Global Market
8.3 Global Cytarabine and Daunorubicin Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Cytarabine and Daunorubicin Supply Chain Analysis
10.1 Cytarabine and Daunorubicin Industry Value Chain
10.2 Cytarabine and Daunorubicin Upstream Market
10.3 Cytarabine and Daunorubicin Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Cytarabine and Daunorubicin Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Cytarabine and Daunorubicin in Global Market
Table 2. Top Cytarabine and Daunorubicin Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Cytarabine and Daunorubicin Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Cytarabine and Daunorubicin Revenue Share by Companies, 2018-2023
Table 5. Global Cytarabine and Daunorubicin Sales by Companies, (K Units), 2018-2023
Table 6. Global Cytarabine and Daunorubicin Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Cytarabine and Daunorubicin Price (2018-2023) & (USD/Unit)
Table 8. Global Manufacturers Cytarabine and Daunorubicin Product Type
Table 9. List of Global Tier 1 Cytarabine and Daunorubicin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Cytarabine and Daunorubicin Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Cytarabine and Daunorubicin Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Cytarabine and Daunorubicin Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Cytarabine and Daunorubicin Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Cytarabine and Daunorubicin Sales (K Units), 2018-2023
Table 15. By Type - Global Cytarabine and Daunorubicin Sales (K Units), 2024-2029
Table 16. By Application – Global Cytarabine and Daunorubicin Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Cytarabine and Daunorubicin Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Cytarabine and Daunorubicin Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Cytarabine and Daunorubicin Sales (K Units), 2018-2023
Table 20. By Application - Global Cytarabine and Daunorubicin Sales (K Units), 2024-2029
Table 21. By Region – Global Cytarabine and Daunorubicin Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Cytarabine and Daunorubicin Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Cytarabine and Daunorubicin Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Cytarabine and Daunorubicin Sales (K Units), 2018-2023
Table 25. By Region - Global Cytarabine and Daunorubicin Sales (K Units), 2024-2029
Table 26. By Country - North America Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Cytarabine and Daunorubicin Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Cytarabine and Daunorubicin Sales, (K Units), 2018-2023
Table 29. By Country - North America Cytarabine and Daunorubicin Sales, (K Units), 2024-2029
Table 30. By Country - Europe Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Cytarabine and Daunorubicin Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Cytarabine and Daunorubicin Sales, (K Units), 2018-2023
Table 33. By Country - Europe Cytarabine and Daunorubicin Sales, (K Units), 2024-2029
Table 34. By Region - Asia Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Cytarabine and Daunorubicin Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Cytarabine and Daunorubicin Sales, (K Units), 2018-2023
Table 37. By Region - Asia Cytarabine and Daunorubicin Sales, (K Units), 2024-2029
Table 38. By Country - South America Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Cytarabine and Daunorubicin Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Cytarabine and Daunorubicin Sales, (K Units), 2018-2023
Table 41. By Country - South America Cytarabine and Daunorubicin Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Cytarabine and Daunorubicin Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Cytarabine and Daunorubicin Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Cytarabine and Daunorubicin Sales, (K Units), 2024-2029
Table 46. Celator Pharmaceuticals Company Summary
Table 47. Celator Pharmaceuticals Cytarabine and Daunorubicin Product Offerings
Table 48. Celator Pharmaceuticals Cytarabine and Daunorubicin Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 49. Celator Pharmaceuticals Key News & Latest Developments
Table 50. Jazz Pharma Company Summary
Table 51. Jazz Pharma Cytarabine and Daunorubicin Product Offerings
Table 52. Jazz Pharma Cytarabine and Daunorubicin Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2018-2023)
Table 53. Jazz Pharma Key News & Latest Developments
Table 54. Cytarabine and Daunorubicin Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 55. Global Cytarabine and Daunorubicin Capacity Market Share of Key Manufacturers, 2021-2023
Table 56. Global Cytarabine and Daunorubicin Production by Region, 2018-2023 (K Units)
Table 57. Global Cytarabine and Daunorubicin Production by Region, 2024-2029 (K Units)
Table 58. Cytarabine and Daunorubicin Market Opportunities & Trends in Global Market
Table 59. Cytarabine and Daunorubicin Market Drivers in Global Market
Table 60. Cytarabine and Daunorubicin Market Restraints in Global Market
Table 61. Cytarabine and Daunorubicin Raw Materials
Table 62. Cytarabine and Daunorubicin Raw Materials Suppliers in Global Market
Table 63. Typical Cytarabine and Daunorubicin Downstream
Table 64. Cytarabine and Daunorubicin Downstream Clients in Global Market
Table 65. Cytarabine and Daunorubicin Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Cytarabine and Daunorubicin Segment by Type in 2022
Figure 2. Cytarabine and Daunorubicin Segment by Application in 2022
Figure 3. Global Cytarabine and Daunorubicin Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Cytarabine and Daunorubicin Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Cytarabine and Daunorubicin Revenue, 2018-2029 (US$, Mn)
Figure 7. Cytarabine and Daunorubicin Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Cytarabine and Daunorubicin Revenue in 2022
Figure 9. By Type - Global Cytarabine and Daunorubicin Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Cytarabine and Daunorubicin Revenue Market Share, 2018-2029
Figure 11. By Type - Global Cytarabine and Daunorubicin Sales Market Share, 2018-2029
Figure 12. By Type - Global Cytarabine and Daunorubicin Price (USD/Unit), 2018-2029
Figure 13. By Application - Global Cytarabine and Daunorubicin Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Cytarabine and Daunorubicin Revenue Market Share, 2018-2029
Figure 15. By Application - Global Cytarabine and Daunorubicin Sales Market Share, 2018-2029
Figure 16. By Application - Global Cytarabine and Daunorubicin Price (USD/Unit), 2018-2029
Figure 17. By Region - Global Cytarabine and Daunorubicin Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Cytarabine and Daunorubicin Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Cytarabine and Daunorubicin Revenue Market Share, 2018-2029
Figure 20. By Region - Global Cytarabine and Daunorubicin Sales Market Share, 2018-2029
Figure 21. By Country - North America Cytarabine and Daunorubicin Revenue Market Share, 2018-2029
Figure 22. By Country - North America Cytarabine and Daunorubicin Sales Market Share, 2018-2029
Figure 23. US Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Cytarabine and Daunorubicin Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Cytarabine and Daunorubicin Sales Market Share, 2018-2029
Figure 28. Germany Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 29. France Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Cytarabine and Daunorubicin Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Cytarabine and Daunorubicin Sales Market Share, 2018-2029
Figure 37. China Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 41. India Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Cytarabine and Daunorubicin Revenue Market Share, 2018-2029
Figure 43. By Country - South America Cytarabine and Daunorubicin Sales Market Share, 2018-2029
Figure 44. Brazil Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Cytarabine and Daunorubicin Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Cytarabine and Daunorubicin Sales Market Share, 2018-2029
Figure 48. Turkey Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Cytarabine and Daunorubicin Revenue, (US$, Mn), 2018-2029
Figure 52. Global Cytarabine and Daunorubicin Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Cytarabine and Daunorubicin by Region, 2022 VS 2029
Figure 54. Cytarabine and Daunorubicin Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界のシタラビン＆ダウノルビシン市場予測2023-2029：ダウノルビシン29mg/m2＆シタラビン65mg/m2、ダウノルビシン44mg/m2＆シタラビン100mg/m2] (コード：MMG23LY8445)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のシタラビン＆ダウノルビシン市場予測2023-2029：ダウノルビシン29mg/m2＆シタラビン65mg/m2、ダウノルビシン44mg/m2＆シタラビン100mg/m2]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界のダウノルビシン市場2022年：静脈、点滴
  • 世界のテセントリク市場予測2023-2029：60mg/ml、その他
  • 世界のレブラミド市場予測2023-2029：10mg、25mg、その他
  • 世界のタシグナ市場予測2023-2029：50mg、200mg、その他
  • 世界のサンドスタチンLAR市場予測2023-2029：500mcg、1000mcg、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆